FDA provides resources on pharmaceutical quality topics, including information on regulations, guidance documents, and compliance programs.
Similar Posts
FDA’s ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience
FDA’s Center for Drug Evaluation and Research (CDER) recently accepted a new submission into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. This submission is the first artificial intelligence-based and digital health technology-based project and the first proJoint US FDA – Health Canada ICH Public Meeting – 02/22/2024
Joint US FDA – Health Canada ICH Public MeetingEssential Pharmacy Compounding, Omaha, NE., 483 Issued 05/22/2015
Task Description Request Please post to the 2015 Pharmacy Inspections and Related Records page.
Record Date 05/22/2015
FEI Number 3003718003
Firm Name Essential Pharmacy Compounding
Record Type 483
State NE
Establishment Type Producer of Sterile Drug ProductsCentral Admixture Pharmacy Services Inc. Phoenix, AZ. 483 issued 09/05/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 09/05/2025
Short Title (70 char) Central Admixture Pharmacy Services Inc. Phoenix, AZ. 483 issued 09/05/2025
FEI Number 3014307835
Firm Name Central Admixture Pharmacy Services Inc
Record Type 483
State AZ
EstabGerber Products Company Announces Voluntary Recall of Limited Batches of Arrowroot Biscuits Out of an Abundance of Caution Due to Potential Presence of Foreign Material Following Supplier Recall
January 26, 2026 — Gerber Products Company is initiating a voluntary recall of limited batches of Gerber® Arrowroot Biscuits out of an abundance of caution due to the potential presence of soft plastic and/or paper pieces that should not be consumed. The material comes from an arrowroot flour suppliEarly Alert: Stent and Electrocautery-Enhanced Delivery System Issue from Boston Scientific
Boston Scientific is removing certain stents and delivery systems due to issues with deployment and expansion.